Company intelligence / Profile preview
Dios Lifesciences
- Ownership
- Private
- Employees
- ~151
- Development stage
- Other
Overview
Dios Lifesciences markets a broad portfolio of branded generic pharmaceuticals in India spanning multiple dosage forms and therapeutic areas. No recent clinical trial or pipeline innovation results are publicly noted; the company focuses on commercial distribution and market penetration of established formulations.[1][3][7]
- Therapeutic areas
- CardiovascularEndocrinologyGastroenterologyNeurologyMetabolic DisordersOtherMen's Health
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
8 assets7 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Dios Lifesciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dios Lifesciences.